Stockreport

Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report [Yahoo! Finance]

Catheter Precision, Inc.  (VTAK) 
PDF of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q1 Financials, Operational Report for the quarter ending March 31, 2024. Operational [Read more]